Series A - Acclinate
Investment Firm
Overview
Acclinate is a digital health company helping pharma diversify clinical trials by accessing and engaging communities of color.
Announced Date
May 07, 2024
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
3
| Investor Name |
|---|
 LabCorp |
Round Details and Background
Acclinate raised $7000000 on 2024-05-07 in Series A
Acclinate is a digital health company helping pharma diversify clinical trials by accessing and engaging communities of color.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 01, 2021 |  Pre Seed Round - Acclinate | 6 | - | 1.4M |
| Oct 19, 2022 | Seed Round - Acclinate | 1 | - | 4.9M |
| Jul 22, 2021 | Non Equity Assistance - Acclinate | 1 | - | undefined |
| May 07, 2024 | Series A - Acclinate | 3 | - | 7.0M |
Recent Activity
There is no recent news or activity for this profile.